Home›Search›Forum on Immunopathological Diseases and Therapeutics

Forum on Immunopathological Diseases and Therapeutics

Begell House Inc. · United States · Est. 2010

ISSN2151-8025

SJR Q4✓ Scopus / SJR

Journal Impact Factor

Not on record at PubScope. The Journal Impact Factor is published by Clarivate for Web of Science (JCR)–indexed journals.

📊 Standing in its field

Where this journal ranks among others in the same subject area.

SJR · Scopus

Bottom 25%

Clarivate’s JCR quartile is a separate ranking and may differ

SJR Scorei

0.105

H-Indexi

Total Worksi

220

Total Citationsi

1,108

2yr Mean Citednessi

0.00

Open Impact Factor alternative

Aims & Scope

Subject areas: Biochemistry; Biotechnology; Genetics; Molecular Medicine.

General Information

Country / RegionUnited States

Primary Language—

1st Year Published2010

Annual Volume~ 32 articles / year

StatusActive (last: 2016)

Total Publications220

Publisher OrgBegell House

Submission Info

Peer Review—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

4/11 · 36%

✅

Do you know the journal / publisher?

Begell House Inc.

❌

Does the journal have a website?

No URL

✅

Is the ISSN verified?

2151-8025

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

❌

Primary language documented?

N/A

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Citations received

173

2010

141

2011

186

2012

2013

2014

291

2015

242

2016

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification

Scopus Categories

Molecular MedicineGeneticsBiotechnologyBiochemistry

Research Topics (OpenAlex)

Cancer Mechanisms and TherapyMelanoma and MAPK PathwaysTuberculosis Research and EpidemiologyNitric Oxide and Endothelin EffectsNF-κB Signaling PathwaysImmune Cell Function and InteractionKruppel-like factors researchHIV Research and TreatmentSynthesis and biological activityCell death mechanisms and regulation

Frequently asked questions about Forum on Immunopathological Diseases and Therapeutics

Is Forum on Immunopathological Diseases and Therapeutics a predatory journal?

PubScope has no integrity flags on record for Forum on Immunopathological Diseases and Therapeutics: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.

What is the impact factor of Forum on Immunopathological Diseases and Therapeutics?

Forum on Immunopathological Diseases and Therapeutics is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.105.

Is Forum on Immunopathological Diseases and Therapeutics indexed in Scopus and Web of Science?

Forum on Immunopathological Diseases and Therapeutics is indexed in Scopus.

What is the aims and scope of Forum on Immunopathological Diseases and Therapeutics?